Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC34A1 | Q06495 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | BTN3A1 | O00481 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Medronic Acid SCHEMBL7753674 | 0.91 | SLC34A1 (0.33) | SLC34A1KDM4EMMP2THRBMAPK1 | |
| Medronic Acid SCHEMBL556782 | 0.91 | SLC34A1 (0.33) | SLC34A1KDM4EMMP2THRBMAPK1 | |
| Medronic Acid SCHEMBL5423104 | 0.91 | SLC34A1 (0.33) | SLC34A1KDM4EMMP2THRBMAPK1 | |
| Medronic Acid SCHEMBL9645616 | 0.91 | SLC34A1 (0.33) | SLC34A1KDM4EMMP2THRBMAPK1 | |
| Medronic Acid SCHEMBL409013 | 0.91 | LMNA (0.35) | SLC34A1KDM4EMMP2THRBMAPK1 | |
| Medronic Acid SCHEMBL27529621 | 0.91 | SLC34A1 (0.33) | SLC34A1KDM4EMMP2THRBMAPK1 | |
| Medronic Acid SCHEMBL8712848 | 0.91 | SLC34A1 (0.33) | SLC34A1KDM4EMMP2THRBMAPK1 | |
| Medronic Acid SCHEMBL5267588 | 0.91 | SLC34A1 (0.43) | SLC34A1KDM4EMMP2THRBMAPK1 | |
| Medronic Acid SCHEMBL2801380 | 0.91 | SLC34A1 (0.33) | SLC34A1KDM4EMMP2THRBMAPK1 | |
| Medronic Acid SCHEMBL15129297 | 0.91 | SLC34A1 (0.33) | SLC34A1KDM4EMMP2THRBMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116106469-A | Method for determining radiochemical purity of 99mTc-MDP injection | 原子高科股份有限公司 | 2023-05-12 | — | — | CN | claimed |
| CN-221512858-U | Liquid agent standing device | 福安药业集团烟台只楚药业有限公司 | 2024-08-13 | — | — | CN | disclosed |
| CN-116106469-A | Method for determining radiochemical purity of 99mTc-MDP injection | 原子高科股份有限公司 | 2023-05-12 | — | — | CN | disclosed |
| CN-103203032-B | Technetium [99Tc] methylenediphosphonate preparation and preparation method thereof | 成都云克药业有限责任公司 | 2017-05-17 | — | — | CN | disclosed |
| US-5723102-A | Process for the preparation of an organ-specific substance labeled with technetium-99m | CIS BIO INTERNATIONAL (FR) | 1998-03-03 | — | — | US | disclosed |
| US-5164175-A | Cancer detection | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-11-17 | — | — | US | disclosed |
| US-5116596-A | Complexed reducing agent | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-05-26 | — | — | US | disclosed |
| US-4638809-A | Method of preparing radionuclide doses | KUPERUS JOHN H | 1987-01-27 | — | — | US | disclosed |
| US-4313928-A | Composition for labeling of red blood cells with radioactive technetium | NIHON MEDI-PHYSICS CO., LTD. (JP) | 1982-02-02 | — | — | US | disclosed |
| EP-0011301-A1 | Composition and method for labelling red blood cells with radioactive technetium; process and kit for preparing the composition | NIHON MEDI-PHYSICS CO., LTD. (JP) | 1980-05-28 | — | — | EP | disclosed |